178 related articles for article (PubMed ID: 16327328)
1. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis.
Breton G; Adle-Biassette H; Therby A; Ramanoelina J; Choudat L; Bissuel F; Huerre M; Dromer F; Dupont B; Lortholary O
AIDS; 2006 Jan; 20(1):119-21. PubMed ID: 16327328
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of the treatment and secondary antifungal prophylaxis in AIDS-related histoplasmosis. Experience at the Francisco J. Muñiz Infectious Diseases Hospital in Buenos Aires].
Negroni R; Messina F; Arechavala A; Santiso G; Bianchi M
Rev Iberoam Micol; 2017; 34(2):94-98. PubMed ID: 28391953
[TBL] [Abstract][Full Text] [Related]
3. Histoplasmosis-associated immune reconstitution inflammatory syndrome.
Passos L; Talhari C; Santos M; Ribeiro-Rodrigues R; Ferreira LC; Talhari S
An Bras Dermatol; 2011; 86(4 Suppl 1):S168-72. PubMed ID: 22068802
[TBL] [Abstract][Full Text] [Related]
4. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.
Wheat J; Hafner R; Korzun AH; Limjoco MT; Spencer P; Larsen RA; Hecht FM; Powderly W
Am J Med; 1995 Apr; 98(4):336-42. PubMed ID: 7709945
[TBL] [Abstract][Full Text] [Related]
5. Successful discontinuation of secondary prophylaxis for histoplasmosis after highly active antiretroviral therapy.
Sun HY; Chen MY; Hsieh SM; Hung CC; Chang SC
J Formos Med Assoc; 2004 Jul; 103(7):546-8. PubMed ID: 15318277
[TBL] [Abstract][Full Text] [Related]
6. Treatment of disseminated histoplasmosis in advanced HIV using itraconazole with increased bioavailability.
Mangalore RP; Moso MA; Cronin K; Young K; McMahon JH
Int J STD AIDS; 2018 Dec; 29(14):1448-1450. PubMed ID: 30114999
[TBL] [Abstract][Full Text] [Related]
7. Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosis.
Crommentuyn KM; Mulder JW; Sparidans RW; Huitema AD; Schellens JH; Beijnen JH
Clin Infect Dis; 2004 Apr; 38(8):e73-5. PubMed ID: 15095234
[TBL] [Abstract][Full Text] [Related]
8. Case of disseminated histoplasmosis in a HIV-infected patient revealed by nasal involvement with maxillary osteolysis.
Lehur AC; Zielinski M; Pluvy J; Grégoire V; Diamantis S; Bleibtreu A; Rioux C; Picard A; Vallois D
BMC Infect Dis; 2017 May; 17(1):328. PubMed ID: 28476105
[TBL] [Abstract][Full Text] [Related]
9. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS.
Posada-Vergara MP; Lindoso JA; Tolezano JE; Pereira-Chioccola VL; Silva MV; Goto H
J Infect Dis; 2005 Nov; 192(10):1819-22. PubMed ID: 16235183
[TBL] [Abstract][Full Text] [Related]
10. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.
Goldman M; Zackin R; Fichtenbaum CJ; Skiest DJ; Koletar SL; Hafner R; Wheat LJ; Nyangweso PM; Yiannoutsos CT; Schnizlein-Bick CT; Owens S; Aberg JA;
Clin Infect Dis; 2004 May; 38(10):1485-9. PubMed ID: 15156489
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Trends in Immune Reconstitution Inflammatory Syndrome Associated With Histoplasma capsulatum Among People Living With Human Immunodeficiency Virus: A 20-Year Case Series and Literature Review.
Melzani A; de Reynal de Saint Michel R; Ntab B; Djossou F; Epelboin L; Nacher M; Blanchet D; Demar M; Couppie P; Adenis A
Clin Infect Dis; 2020 Feb; 70(4):643-652. PubMed ID: 30921453
[TBL] [Abstract][Full Text] [Related]
12. Temporal trends, clinical characteristics, and outcomes of histoplasmosis in a tertiary care center in Kentucky, 2000 to 2009.
Myint T; Al-Hasan MN; Ribes JA; Murphy BS; Greenberg RN
J Int Assoc Provid AIDS Care; 2014; 13(2):100-5. PubMed ID: 24029651
[TBL] [Abstract][Full Text] [Related]
13. Disseminated histoplasmosis in an AIDS patient with immunologic non-response to HAART: A case report.
Adekanmbi O; Nwanji I; Oladele R
J Mycol Med; 2022 Aug; 32(3):101271. PubMed ID: 35298932
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic relapse of HIV-associated cryptococcal meningitis: recurrent cryptococcal meningitis or Cryptococcus-related immune reconstitution inflammatory syndrome?
Jhamb R; Kashyap B; Das S; Berry N; Garg A
Int J STD AIDS; 2014 Apr; 25(5):369-72. PubMed ID: 24108453
[TBL] [Abstract][Full Text] [Related]
15. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras.
Peigne V; Dromer F; Elie C; Lidove O; Lortholary O;
Am J Trop Med Hyg; 2011 Nov; 85(5):934-41. PubMed ID: 22049053
[TBL] [Abstract][Full Text] [Related]
16. Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy.
Buckingham SJ; Haddow LJ; Shaw PJ; Miller RF
Clin Radiol; 2004 Jun; 59(6):505-13. PubMed ID: 15145720
[TBL] [Abstract][Full Text] [Related]
17. The immune reconstitution inflammatory syndrome.
Shelburne SA; Hamill RJ
AIDS Rev; 2003; 5(2):67-79. PubMed ID: 12876896
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.
Shelburne SA; Visnegarwala F; Darcourt J; Graviss EA; Giordano TP; White AC; Hamill RJ
AIDS; 2005 Mar; 19(4):399-406. PubMed ID: 15750393
[TBL] [Abstract][Full Text] [Related]
19. Immune reconstitution inflammatory syndrome in an HIV-infected patient with disseminated coccidioidomycosis.
Lin AY; Chun V; Dhamija A; Bordin-Wosk T; Kadakia A
Int J STD AIDS; 2019 Aug; 30(9):923-926. PubMed ID: 31159717
[No Abstract] [Full Text] [Related]
20. Correlation of CD4 counts with clinical and histopathological findings in disseminated histoplasmosis: a 10-year retrospective study.
Sirait SP; Bramono K; Hermanto N
Int J Dermatol; 2017 Sep; 56(9):926-931. PubMed ID: 28677260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
